Clinical Trial Update: GnRH Therapy on Cognition in Down Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial investigating GnRH therapy for cognitive decline in individuals with Down syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease Early Onset
• Cognitive Decline
• Down Syndrome
• Olfactory Disorders

Drugs mentioned

• GnRH therapy (Gonadotropin-releasing hormone therapy)

Snippet

Sponsor: Nelly Pitteloud | Conditions: Down Syndrome, Cognitive Decline | Phase 2, Phase 3 | Status: RECRUITING